Heyman Richard A. 4
4 · Enliven Therapeutics, Inc. · Filed Feb 19, 2026
Research Summary
AI-generated summary of this filing
Enliven Therapeutics (ELVN) Director Richard Heyman Sells Shares
What Happened
Richard A. Heyman, a director of Enliven Therapeutics (ELVN), sold 1,230 shares in an open‑market transaction on February 17, 2026. The weighted average sale price was $26.18 per share for total proceeds of $32,196. The sale is reported as a disposition (transaction code S).
Key Details
- Transaction date: February 17, 2026; Form 4 filed February 19, 2026 (timely filing).
- Price: weighted average $26.18; individual trades ranged from $25.765 to $26.6949.
- Shares sold: 1,230; total proceeds reported: $32,196.
- Footnotes: sale was effected under a Rule 10b5‑1 trading plan adopted Nov 15, 2024 (the plan covers shares held by the Heyman Daigle Trust); reporting person is trustee of the Heyman Daigle Trust. The filing notes the shares are held of record by the Heyman Daigle Trust and by RAHD Capital LLC (for which Heyman is managing member). The filer offers to provide trade‑by‑trade price/quantity details upon SEC/issuer/requestor request.
- Shares owned after the transaction: not specified in the provided filing details.
Context
This was a sale executed under a pre‑arranged 10b5‑1 plan, which is commonly used to schedule trades in advance and is considered a routine method for insiders to dispose of shares. The filing is informational and does not, by itself, indicate the insider’s current view on the company.
Insider Transaction Report
Form 4
Heyman Richard A.
Director
Transactions
- Sale
Common Stock
[F1][F2][F3]2026-02-17$26.18/sh−1,230$32,196→ 22,647 total(indirect: See footnote)
Holdings
- 123,673
Common Stock
- 25,545(indirect: See footnote)
Common Stock
[F4]
Footnotes (4)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 15, 2024 by the Reporting Person and by Richard A. Heyman and Anne E. Daigle Trust, UAD 01/01/1995, as amended November 1, 2016, for which the Reporting Person serves as trustee (the "Heyman Daigle Trust").
- [F2]This transaction was executed in multiple trades at prices ranging from $25.765 to $26.6949. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F3]The shares are held of record by the Heyman Daigle Trust.
- [F4]The shares are held of record by RAHD Capital LLC, for which the Reporting Person serves as a managing member.
Signature
/s/ Ben Hohl, by power of attorney|2026-02-19